5 Things To Know About Ocrevus Dosage

The multiple sclerosis community is buzzing with news of the recent FDA approval of the drug Ocrevus (ocrelizumab) which can be used in the treatment of relapsing-remitting multiple sclerosis (RRMS) and is the first approved drug for the treatment of primary-progressive multiple sclerosis (PPMS).

But how is the drug taken? Here are five important things to know about the dosage and administration of Ocrevus according to everydayhealth.com.

How is it administered?
The first dosage of Ocrevus is delivered via two intravenous infusions, which are taken two weeks apart. Patients will then have further IV infusions every six months.

What is the dosage?
In the clinical trials for the drug, PPMS patients were given 300mg of Ocrevus at each infusion (600mg a month).

Where is it given?
Ocrevus should be given to patients in a clinical setting by a healthcare professional so that patients can be monitored for any adverse reactions.

Ocrevus approval: A quick cheat sheet.

5 comments

  1. Lori says:

    Can’t wait to try it and find out hw it works
    with P.P. MS my DR says I’m called a non responder.
    Hey guys and Gals,
    ONCE ON MY SITE YOU CAN VISIT
    “ANGELS AMONG US” WHICH IS ON THE FAR RIGHT OF MY SITE ,DRAG OUR USOR TO MORE AND YOUR CARETAKER CAN LEAVE THIER COMMENT.

    THANKS LORI

  2. Lynne says:

    I wonder how useful Ocrevus would be for

    PPMS patients who already are significantly disabled. I’m thinking it would show more promise for the newly diagnosed.

Leave a Comment

Your email address will not be published. Required fields are marked *